International Journal of Head and Neck Surgery

Register      Login

VOLUME 7 , ISSUE 1 ( January-March, 2016 ) > List of Articles

REVIEW ARTICLE

Management of Early Laryngeal Cancer: The Role of Individualized Medicine

Gady Har-El

Citation Information : Har-El G. Management of Early Laryngeal Cancer: The Role of Individualized Medicine. Int J Head Neck Surg 2016; 7 (1):23-28.

DOI: 10.5005/jp-journals-10001-1260

Published Online: 01-03-2016

Copyright Statement:  Copyright © 2016; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

How to cite this article

Har-El G. Management of Early Laryngeal Cancer: The Role of Individualized Medicine. Int J Head Neck Surg 2016;7(1):23-28.


PDF Share
  1. Cancer statistics. CA Cancer J Clin 2007;57:43-66.
  2. Atlanta: American Cancer Society; 2010.
  3. Tumours of the hypopharynx, larynx, and trachea introduction. In: Barnes L, Eveson J, Reichart P, Sidramsky, D, editors. WHO classification of tumours: pathology and genetics of head and neck tumours. Lyon, France: IARC Press; 2005. p. 111-117.
  4. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 2006;116 (suppl 111):1-13.
  5. 7th edn. New York: Spring; 2010.
  6. What treatment for early-stage glottic carcinoma among adult patients: CO2 endolaryngeal laser excision versus standard fractionated external beam radiation is superior in terms of cost utility? Laryngoscope 2011;121:116-134.
  7. Evidence-based review of treatment options for patients with glottic cancer. Laryngoscope 2014;124:1398-1401.
  8. Glottic laser surgery: outcomes according to 2007 ELS classification. Eur Arch Otorhinolaryngol 2011;268:1771-1778.
  9. Endoscopic laser resection of laryngeal cancer: is it oncologically safe? Ann Otol Rhinol Laryngol 2009;118:399-404.
  10. Impact of second primary tumors on survival in head and neck cancer: an analysis of 2,063 cases. Laryngoscope 2008;118:1350-1356.
  11. Second malignancies in early stage laryngeal carcinoma patients treated with radiotherapy. J Laryngol Otol 2002;116:190-193.
  12. Second primary cancers in patients with laryngeal cancer: a population-based study. Int J Radiat Oncol Biol Phys 2003;56:427-435.
  13. T1 glottic carcinoma: do comorbidities, facility characteristics and sociodemographics explain survival differences across treatment types? Otolaryngol Head and Neck Surg 2015;152:856-862.
  14. Treatment, survival, and costs of laryngeal cancer care in the elderly. Laryngoscope 2014;124:1827-1835.
  15. Cost-minimisation and cost-effectiveness analysis comparing transoral CO2 laser cordectomy, laryngofissure cordectomy and radiotherapy for the treatment of T1-2, No, Mo glottic carcinoma. Eur Arch Otorhinolaryngol 2013;270:1181-1188.
  16. Radiotherapy versus surgery for early T1-T2 glottic carcinoma. J Otolaryngol 2006;35:413-419.
  17. Transoral laser microsurgery versus radiation therapy for early glottis cancer in Canada: cost analysis. J Otolaryngol Head and Neck Surg 2009;38:619-623.
  18. Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck. Head Neck 2002;24:115-126.
  19. Laser surgery versus radiotherapy for T1-T2 No glottis cancer: a meta-analysis. ORL 2011;73:336-342.
  20. Voice-related quality of life in T1 glottic cancer: irradiation versus endoscopic excision. Ann Otol Rhinol Laryngol 2006;115:581-586.
  21. Voice outcomes following radiation versus laser microsurgery for T1 glottic carcinoma: systematic review and meta-analysis. Otolaryngol Head Neck Surg 2015;152:811-819.
  22. Cordectomy by CO2 laser or radiotherapy for small T1a carcinomas: costs, local control, survival, quality of life, and voice quality. Head Neck 2007;29:128-136.
  23. Prospective evaluation of voice outcome during the first two years in male patients treated by radiotherapy or laser surgery for T1a glottis carcinoma. Eur Arch Otorhinolaryngol 2012;269:1647-1652.
  24. Voice quality after CO2 laser cordectomy-what can we really expect? Head Neck 2008; 30:43-49.
  25. Treatment of early-stage glottic cancer: meta-analysis comparison of laser excision versus radiotherapy. J Otolaryngol Head Neck Surg 2009;38:603-612.
  26. Difference in survival outcome between stage I and stage II glottic cancer: a SEER-based analysis. Laryngoscope 2015;125:2093-2098.
  27. Laryngeal reconstruction following CO2 laser surgery for glottic cancer. Head Neck 2009;31:1369-1376.
  28. Medialization framework surgery for voice improvement after endoscopic cordectomy. Eur Arch Otorhinolaryngol 2001;258:267-271.
  29. Phonosurgical reconstruction of early glottic cancer. Laryngoscope 2001;111:1862-1865.
  30. Comparison of endoscopic laser resection versus radiation therapy for the treatment of early glottic carcinoma. J Otolaryngol Head Neck Surg 2011;40:200-204.
  31. Treatment considerations for early glottic carcinoma: lessons learned and a primer for the general otolaryngologist. Otolaryngol Head Neck Surg 2014; 150:169-173.
  32. Endoscopic cordectomy: a proposal for a classification by the working committee, European Laryngological Society. Eur Arch Otolaryngol 2000;257:227-231.
  33. Partial laryngectomy with imbrication laryngoplasty for glottic carcinoma. Arch Otolaryngol Head Neck Surg 2003;129:66-71.
  34. Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer. Cochrane Database Syst Rev 2002;CD002027.
  35. Oncologic efficacy of angiolytic KTP laser treatment of early glottic cancer. Ann Otol Rhinol Laryngol 2014;123:840-846.
  36. Radiotherapy for T1 and T2 laryngeal cancer: the Dalhousie University experience. J Otolaryngol Head Neck Surg 2009;38:434-439.
  37. The role of hemi-laryngectomy in the management of T1 vocal cord cancer. Arch Otolaryngol Head Neck Surg 1989;115:677-680.
  38. Higher laryngeal preservation rate after CO2 laser surgery compared with radiotherapy in T1 glottic laryngeal carcinoma. Head neck 2009;31:759-764.
  39. Arch Otolaryngol Head Neck Surg 2009;135:479-486.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.